Related Experiment Video

Updated: Jul 15, 2026

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumour

Maggie K-L Fung1, Hiu-Wing Cheung, Hing-Lok Wong

  • 1Cancer Biology Group, Department of Anatomy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Hong Kong, SAR, China.

Biochimica Et Biophysica Acta
|May 1, 2007
PubMed

Insights

Testicular germ cell tumours often show chromosomal instability due to defects in the mitotic checkpoint. Reduced expression of Mitotic Arrest Deficient 2 (MAD2) in these cells correlates with this checkpoint impairment.

Area of Science:

  • Oncology
  • Cell Biology
  • Genetics

Background:

  • Chromosomal instability (CIN) is prevalent in testicular germ cell tumours (TGCT).
  • Mitotic checkpoint control ensures accurate chromosome segregation, with Mitotic Arrest Deficient 2 (MAD2) being a crucial component.
  • Impaired mitotic checkpoints are linked to checkpoint dysfunction.

Purpose of the Study:

  • To investigate mitotic checkpoint control function in TGCT cells.
  • To examine the association between mitotic checkpoint function and MAD2 expression in TGCT.
  • To analyze MAD2 expression in TGCT tissues.

Main Methods:

  • Studied 8 TGCT cell lines and 23 TGCT tissue samples.
  • Assessed mitotic arrest response to microtubule disruption.
  • Analyzed MAD2 protein expression via immunohistochemistry.

Main Results:

  • 75% of TGCT cell lines failed to arrest mitosis upon microtubule disruption, indicating checkpoint defects.
  • Loss of mitotic checkpoint control correlated with reduced MAD2 protein expression in TGCT cell lines.
  • Seminoma tissues showed significantly lower nuclear MAD2 expression and higher cytoplasmic expression compared to normal testis tissues.

Conclusions:

  • Defective mitotic checkpoint control is common in TGCT cells.
  • Downregulation of MAD2 is implicated in impaired mitotic checkpoint control in TGCT.
  • Aberrant MAD2 expression may contribute to chromosomal instability in TGCT.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Meiosis II02:02

Meiosis II

Meiosis II entails cell division and segregation of the sister chromatids, resulting in the production of four unique haploid gametes. The steps for meiosis II are similar to mitosis, except that meiosis II occurs in haploid cells, whereas mitosis occurs in diploid cells.
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
Meiosis II01:57

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...